Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...

Buying a dividend stock at a cheap valuation can be a great move for several reasons. If a stock has declined in price but ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country's biopharma sector ...

Merck & Co. Inc. closed 36.37% below its 52-week high of $134.63, which the company reached on June 25th.

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Substack by Long-Term Pick. In this article, we will summarize ...

Most companies don't survive for decades, much less pay regular dividends for that long. Healthcare leaders Merck (NYSE: MRK) ...

The rise of misinformation online has helped fringe health ideas go mainstream and eased RFK Jr.'s path to confirmation as ...

All but one Senate Republican voted for Kennedy, a controversial vaccine critic who used a crusade to "Make America Healthy Again" to win one of the most powerful jobs in Washington.

Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.